Sirtex appoints new CEO
Thursday, 26 May, 2005
Sydney biomedical company Sirtex Medical (ASX:SRX) has promoted Gilman Wong from chief operating officer to chief executive officer.
Wong only joined Sirtex in February 2005 but chairman Bruce Gray said that he "has made a substantial contribution to company activities since then."
Wong has a strong background in sales and marketing -- a potentially useful background for Sirtex, whose sales revenue last year grew 8 per cent to $4.9 million, but whose gross profit fell to $3.57 million from $3.6 million in 2003.
Wong has held senior management positions in the manufacturing, engineering and automotive industries.
Algae unlocks a more ethical way to grow cells
Researchers have combined a new type of Queensland algae, Chlorella sp. BDH-1, with...
Oral drug shows promise for treating Barth syndrome
An oral drug called MA-5 can improve both heart and muscle problems in Barth syndrome, a rare...
New route into cells found for gene therapy viruses
Scientists have identified a previously unknown gateway into human cells — a receptor...
